Bryan G. Helwig, Ph.D.

P: 312.913.3389
F: 312.913.0002

Bryan G. Helwig is an associate with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Helwig concentrates his practice on intellectual property law matters, including patent prosecution, as well as providing infringement and patentability analyses in the biotechnology, pharmaceuticals and medical device and diagnostic areas.

Prior to joining MBHB, Dr. Helwig was a principal investigator for the U.S. Department of Defense wherein he directed a research portfolio tasked with developing pharmaceutical and non-pharmaceutical therapies as well as advancement of molecular device technologies that aid Warfighter survival in extreme environments. The integrative research utilized a wide range of molecular biology, protein chemistry and high throughput technologies. In addition, Dr. Helwig has also served as a consultant to Fortune 500 companies advising on scientific validity of labeling claims, product development and labeling of high protein products. 

Dr. Helwig’s graduate and post-doctoral work focused on transformation of stem cells, heart failure and alterations in central nervous control of autonomic function. Dr. Helwig is an author of various scientific manuscripts, including publications in Physiological Genomics and Stem Cells.

Published Articles

"Beyond Hybrid Licenses— Strategies for Post Patent Expiration Payments in the United States," les Nouvelles - Journal of the Licensing Executives Society, Volume LII No. 1, March 2017.

“Modeling the Intra- and Extracellular Cytokine Signaling Pathway under Heat Stroke.”  PLoS One, E73393; Sep 5, 2013

“A physiological systems approach to modeling and resetting of mouse thermoregulation under heat stress.”J Apply Physiol. 111: 938-45, 2011. 

“Hyperthermia-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system.” Physiol Genomics. 19: 175–83, 2004.

“Matrix Cells from Wharton's Jelly Form Neurons and Glia.” Stem Cells. 21: 50-60, 2003.


PTAB Bar Association

Illinois State Bar Association


Summer 2018 (snippets)
Startup companies often face significant risk and liability with respect to Intellectual Property (IP) on their path to success. The failure to adequately address IP issues can lead to the permanent loss of IP rights and create a litigation risk.
Generate a PDF of your page(s)
Page has been queued
An error has occurred
Added to queue
Confirm Delete All Message
No Items in Packet Message
To add a page, select Add. To view the package, select View.